Navigation Links
Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
Date:6/9/2009

ADCIRCA is a prescription medicine used to treat PAH, a life-threatening disease that constricts the flow of blood through the pulmonary vasculature.

United Therapeutics Corporation licensed the rights to develop, market, promote and commercialize ADCIRCA for pulmonary hypertension in the United States and Puerto Rico from Eli Lilly & Company in November 2008. ADCIRCA contains the same active ingredient as CIALIS(R) (tadalafil), which is marketed by Eli Lilly & Company to treat erectile dysfunction (impotence) in more than 100 countries.

Important Safety Information for ADCIRCA

ADCIRCA should not be used in patients taking medicines that contain nitrates (often used for chest pain) as the combination could cause a sudden, unsafe drop in blood pressure. If a patient experiences anginal chest pain after taking ADCIRCA they should seek immediate medical attention. Patients with a known serious hypersensitivity to tadalafil (ADCIRCA or CIALIS) should not take ADCIRCA.

PDE5 inhibitors, including tadalafil, have mild systemic vasodilatory properties that may result in transient decreases in blood pressure. Before prescribing ADCIRCA, physicians should carefully consider whether their patients with underlying cardiovascular disease could be adversely affected by such effects. Pulmonary vasodilators may significantly worsen the cardiovascular status of patients with pulmonary veno-occlusive disease (PVOD) and administration of ADCIRCA to these patients is not recommended. Patients should discuss their medical condition and all medications with their physician before starting ADCIRCA.

The use of ADCIRCA with alpha blockers, blood pressure medications, and alcohol may cause a lowering of blood pressure. Use of ADCIRCA with potent CYP3A inhibitors, such as ketoconazole and itraconazole, should be avoided. For patients on ADCIRCA therapy that require treatment with ritonavir, dosage adjus
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014  Halozyme Therapeutics, Inc. (NASDAQ: ... enrollment and dosing of patients in its ongoing Phase ... pancreatic cancer under the revised clinical protocol agreed to ... PEGylated form of Halozyme,s proprietary recombinant human hyaluronidase under ... hyaluronan. "Our diligent effort to rapidly ...
(Date:7/22/2014)... -- ConvaTec, a privately-held medical products and technologies company, today ... chief financial officer of the company, effective July 22, ... president and chief financial officer of Elan Corporation, a ... was part of a senior team that helped build ... to Perrigo, a pharmaceutical manufacturer, in December 2013. ...
(Date:7/22/2014)... 22, 2014  UL (Underwriters Laboratories), a global ... Food and Drug Administration (FDA) has recognized two ... medical devices incorporating lithium or nickel-based batteries. The ... Household and Commercial Batteries, and UL 1642 - ... Consensus standards are standards recognized by the FDA ...
Breaking Medicine Technology:Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3ConvaTec Names Nigel Clerkin Chief Financial Officer 2Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices 2
... Women ages 65-69 who break a hip are five times more ... age who don,t break a hip, according to a Kaiser Permanente ... Health and published online today in the Archives of Internal ... by age group. In addition to the finding for women ages ...
... 26, 2011 UHC, an alliance of the nation,s ... a mobile analytics application for Spend LINK®, UHC,s ... subset of Spend LINK® reports that can be ... developed by Novation, UHC,s supply contracting company, allows users ...
Cached Medicine Technology:Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 2Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 3Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 4UHC Launches Analytics Mobile App to Help Members Improve Supply Chain Return on Investment 2UHC Launches Analytics Mobile App to Help Members Improve Supply Chain Return on Investment 3
(Date:7/22/2014)... Greensboro, NC (PRWEB) July 22, 2014 ... and faster for military veterans who have hands-on medical ... North Carolina at Greensboro today announced the launch of ... for military experience. , The new program, the UNCG ... a cohort of approximately 24 veterans. With some prior ...
(Date:7/22/2014)... Rosa Beach, FL (PRWEB) July 22, 2014 ... announce that they are now an authorized Daikin comfort ... offer and install Daikin indoor heating and cooling system ... and each one is thoroughly reviewed before being approved. ... is an innovator in the Split System Air Conditioning ...
(Date:7/22/2014)... Dr. Jeremy K. Ueno, of ... recently discussed the reasons for an increase in patients ... profession are seeing the amount of referrals they get ... one surgeon reported that over 50% of his implant ... have a very high success rate of up to ...
(Date:7/22/2014)... United Benefit Advisors (UBA), the nation's ... McPhearson, an insurance veteran with more than 15 years ... be based in the company's Chicago office. , UBA ... Les chose to accept this important, strategic position with ... many challenges facing UBA and its Partners as we ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 A Florida ... ) that alleges the death of her husband ... the blood thinner, Bernstein Liebhard LLP reports. According to ... District Court for the Southern District of Florida on ... 2012, and suffered a subdural hemorrhage the following June. ...
Breaking Medicine News(10 mins):Health News:UNCG School of Nursing Fast-Tracks Medically Trained Veterans 2Health News:Air Conditioning & Heating Inc. Now an Authorized Daikin Comfort Pro Dealer 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 3Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 3Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 4Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 5Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 3
... at Intermountain Medical Center in Salt Lake City believe ... fibrillation, a fairly common heart rhythm disorder, and Alzheimer,s ... In a study presented Friday, May 15, at "Heart ... Rhythm Society in Boston, researchers unveiled findings from the ...
... HAIKOU CITY, China, May 15 /PRNewswire-Asia-FirstCall/ -- China Pharma,Holdings, Inc. ... specialty pharmaceutical products in China, today,announced financial results for the ... First Quarter 2009 Financial Highlights, -- ... the, first quarter of ...
... Prayerful Approach to Pain in Steinbach, Manitoba , ... Steinbach, Manitoba, Canada ... suffer in silence from chronic pain. Even pop singer, famed choreographer, and ... chronic pain in the May issue of Ladies Home Journal. While ...
... Brookdale Senior Living Inc. (NYSE: BKD ) today ... will make a presentation regarding the Company at the JMP ... 19, 2009, beginning at 2:30 p.m. Pacific Time.The presentation is ... Internet at , http://www.wsw.com/webcast/jmp8/bkd/ ...
... 14, 2009)A study of targeted educational initiatives between the ... hospitals within their Partners program suggest that educational interventions ... for cancer patients at community hospitals. The study, ... the American Society of Clinical Oncology, looked specifically at ...
... cancer patients , , THURSDAY, May 14 (HealthDay News) -- ... many grandmothers are already familiar with, and report that ... , "Ginger at a daily dose of 0.5-to-1 gram ... the first day of chemotherapy, and reduced nausea will ...
Cached Medicine News:Health News:Study makes first connection between heart disorder and Alzheimer's disease 2Health News:China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates 2Health News:China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates 3Health News:China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates 4Health News:China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates 5Health News:China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates 6Health News:China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates 7Health News:China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates 8Health News:Chronic Pain Sufferers Find Hope in the Darkness 2Health News:Educational initiatives improve quality of care delivery 2Health News:Ginger Eases Nausea From Chemo 2
... Arctic Circler uses the same cryoconsole ... AF originating in the pulmonary veins. Arctic ... challenge the traditional palliative-only treatments that rely ... the Arctic Circler catheter has the ability ...
... The Guglielmi Detachable Coil is intended for: ... because of,their morphology, their location, or the ... by the treating,neurosurgical team to be a) ... operative techniques, or b) inoperable.,The GDC is ...
Care must be taken to operate the power unit slowly to help eliminate the possibility of breaking the wires by over-tightening....
Large solid mallet with patented Ortho-Grip® silicone rubber handle....
Medicine Products: